Fiasp FlexTouch Pens 100 Units / mL is a fast-acting type of insulin (insulin aspart) used by adults and children with type 1 or type 2 diabetes. It effectively manages blood glucose (sugar) levels and avoids developing any severe complications.
The Fiasp formulation contains Vitamin B3 (niacinamide) and L-arginine to stabilize the formulation. The type of medication Fiasp produces is called insulin aspart.
It is taken to replace the insulin that is not sufficiently produced by the body and helps properly deliver glucose into cells.
Typically it is prescribed by doctors along with long-acting insulin types and other diabetes medications.
Fiasp insulin should be used as part of a treatment program that should incorporate a proper diet, regular exercise, and weight loss as instructed by your doctor. Fiasp FlexTouch Pens 100 Units / mL
By taking Fiasp insulin as part of your diabetes treatment, it may help create a healthier lifestyle.
Please do not share your Fiasp FlexTouch Pens, needles, or syringes with other patients as it can lead to the transmission of blood-borne pathogens. Fiasp FlexTouch Pens should be loaded with Fiasp cartridges.
Ensure you are ordering the correct pen, as there are many forms of FlexTouch pens and cartridges on the market.
Fiasp insulin is also available in vials.
Adjustment of dose may be necessary if patients undertake increased physical activity, change their usual diet or during concomitant illness. Blood glucose levels should be monitored adequately under these conditions.
The duration of action will vary according to the dose, injection site, blood flow, temperature and level of physical activity.
Patients on basal-bolus treatment who forget a mealtime dose are advised to monitor their blood glucose level to decide if an insulin dose is needed. Patients should resume their usual dosing schedule at the next meal.
The potency of insulin analogues, including Fiasp, is expressed in units. One (1) unit of Fiasp corresponds to 1 international unit of human insulin or 1 unit of other fast-acting insulin analogues.